Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
基本信息
- 批准号:10382081
- 负责人:
- 金额:$ 6.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntiviral AgentsAntiviral TherapyBindingCodon NucleotidesComplexCrystallizationDNADNA BindingDNA Binding DomainDangerousnessDataDevelopmentGenesGenetic VariationHost DefenseHuman GenomeImmune responseInfectionInterferonsKnock-outKnowledgeMammalian CellMediatingModelingMolecularOrthopoxvirusPathway interactionsPattern recognition receptorPeptide Initiation FactorsPhenylalaninePlayPoxviridaeProcessProtein BiosynthesisProteinsRaceRegulationResistanceRibosomal RNARibosomesRodentRoleSignal TransductionSpecies SpecificitySpecificityStructureTransfectionTransfer RNATranslation InitiationTranslationsVaccinia virusViralViral PathogenesisVirusVirus Diseasesarmcellular targetingcytosolic receptords-DNAemerging pathogenexperimental studygenome-wideinhibitor/antagonistinsightnoveloverexpressionparent grantpoxvirus vectorspressureresponseribosome profilingtRNA Methyltransferasestranscriptome sequencingvector vaccine
项目摘要
Project Summary (Parent Grant 1R01AI151638-01A1)
All viruses rely on host translational machinery for protein synthesis. As such, translation
control constitutes a universal host defense against viruses. A new understanding on how host
regulates translation in response to viral infection and how viruses evade this host response will
provide fundamental insight into viral pathogenesis and benefit the development of new antiviral
strategies.
Poxviruses include some dangerous emerging pathogens as well as some promising vaccine
vectors. Unlike many other viruses, poxvirus host range is not affected by the entry step but
restricted by intracellular processes. Particularly, cellular translational control pathways have a
profound impact on poxvirus host range, and poxvirus inhibitors of these pathways could
manifest as critical host-range factors. The best-known example is PKR-mediated control of
translation initiation and its antagonism by two vaccinia virus (VACV) host-range proteins E3
and K3. Much less is understood about a PKR-independent pathway targeted by two critical
VACV host-range proteins, K1 and C7. VACV with deletion in both K1 and C7 fails to replicate
in most mammalian cells due to a shut-off of viral and host protein synthesis. Intriguingly, the
translational shut-off is independent of PKR and RNaseL and appears not to involve any
translation initiation factors. A paralogous pair of interferon-stimulated genes, SAMD9 and
SAMD9L (SAMD9&L), were recently identified by us and others as the specific targets of K1
and C7. However, how they regulate protein synthesis and restrict poxvirus host range is
unknown and is the focus of this proposal.
We have made sustained contributions to the understanding of K1/C7 and their cellular
targets for over a decade, including the determination of the structures of K1/C7 and the
identification of SAMD9L as a cellular target of K1/C7. In addition, we have obtained compelling
preliminary data that led to our novel hypotheses, which will be addressed separately with the
following specific aims.
Aim 1. To determine how SAMD9 is activated to inhibit protein synthesis.
Aim 2. To determine how activated SAMD9 inhibits protein synthesis.
Aim 3. To determine the molecular basis underlying the host species-specific SAMD9&L
inhibition by OPXV inhibitors.
项目摘要(母基金1 R 01 AI 151638 - 01 A1)
所有病毒都依赖宿主翻译机器进行蛋白质合成。因此,翻译
控制构成了针对病毒的通用宿主防御。对主持人的新认识
调节对病毒感染的应答的翻译,以及病毒如何逃避这种宿主应答将
为病毒的发病机理提供了基本的见解,并有利于开发新的抗病毒药物
战略布局
痘病毒包括一些危险的新兴病原体以及一些有前途的疫苗
向量。与许多其他病毒不同,痘病毒的宿主范围不受进入步骤的影响,
受到细胞内过程的限制。特别地,细胞翻译控制途径具有
深刻影响痘病毒宿主范围,这些途径的痘病毒抑制剂可以
表现为关键的宿主范围因素。最著名的例子是PKR介导的对
两种痘苗病毒宿主范围蛋白E3的翻译起始及其拮抗作用
还有K3。关于PKR非依赖性途径的了解要少得多,这一途径由两个关键的
VACV宿主范围蛋白,K1和C7。K1和C7缺失的VACV无法复制
在大多数哺乳动物细胞中,由于病毒和宿主蛋白质合成的关闭。有趣的是,
翻译关闭不依赖于PKR和RNaseL,似乎不涉及任何
翻译起始因子一对旁系同源的干扰素刺激基因SAMD 9和
SAMD 9 L(SAMD9&L)是K1的特异性靶基因
C7的。然而,它们是如何调节蛋白质合成和限制痘病毒宿主范围的,
这是一个未知的问题,也是这个问题的焦点。
我们对K1/C7及其细胞的理解做出了持续的贡献。
十多年来的目标,包括确定K1/C7的结构和
鉴定SAMD 9 L作为K1/C7的细胞靶标。此外,我们还获得了令人信服的
初步的数据,导致我们的新的假设,这将单独解决与
具体目标。
目标1。确定SAMD 9如何被激活以抑制蛋白质合成。
目标2.确定激活的SAMD 9如何抑制蛋白质合成。
目标3.为了确定宿主种特异性SAMD 9 & L
OPXV抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Junpeng Deng其他文献
Junpeng Deng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Junpeng Deng', 18)}}的其他基金
Developing small molecule inhibitors for modulating cytokine IL18 activities
开发调节细胞因子 IL18 活性的小分子抑制剂
- 批准号:
10393624 - 财政年份:2021
- 资助金额:
$ 6.61万 - 项目类别:
Developing small molecule inhibitors for modulating cytokine IL18 activities
开发调节细胞因子 IL18 活性的小分子抑制剂
- 批准号:
10226420 - 财政年份:2021
- 资助金额:
$ 6.61万 - 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
- 批准号:
10463680 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Structure function studies of a molecular complex for generating viral membrane
用于生成病毒膜的分子复合物的结构功能研究
- 批准号:
10170273 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
- 批准号:
10680408 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
- 批准号:
10675831 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus
痘病毒宿主范围限制的新型翻译控制机制
- 批准号:
10267770 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Structure function studies of a molecular complex for generating viral membrane
用于生成病毒膜的分子复合物的结构功能研究
- 批准号:
10057852 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Non-vesicular lipid transport by poxvirus A6 protein
痘病毒 A6 蛋白的非囊泡脂质转运
- 批准号:
9379762 - 财政年份:2017
- 资助金额:
$ 6.61万 - 项目类别:
Structure-function studies on a key signaling module from interleukin 17 receptor
白细胞介素17受体关键信号模块的结构-功能研究
- 批准号:
8771995 - 财政年份:2014
- 资助金额:
$ 6.61万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 6.61万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 6.61万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 6.61万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 6.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 6.61万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 6.61万 - 项目类别: